Antibodies to heat shock proteins in schizophrenic patients: Implications for the mechanism of the disease

American Journal of Psychiatry

Volumn 156, Issue 7, 1999, Pages 1103-1104

  Schwarz, Markus J ^a,b   Riedel, Michael ^a   Gruber, Rudolf ^a   Ackenheil, Manfred ^a   Müller, Norbert ^a  

^a AGNP   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIBODIES; ANTIBODY FORMATION; ANTIPSYCHOTIC AGENTS; CHAPERONIN 60; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; SCHIZOPHRENIA;

EID: 0032968669     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Prabhakar S, Kurien E, Gupta RS, Zielinski S, Freedman MS: Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease. Neurology 1994;44:1644-1648
2. Battistini L, Salvetti M, Ristori G, Falcone M, Raine CS, Brosnan CF: γδ T cell receptor analysis supports a role for HSP 70 selection of lymphocytes in multiple sclerosis lesions. Mol Med 1995; 1:554-562
3. Kilidireas K, Latov N, Strauss DH, Aviva DG, Hashim GA, Gorman JM, Sadiq SA: Antibodies to human 60 kD heatshock protein in patients with schizophrenia. Lancet 1992; 340:569-572
4. Schwarz MJ, Riedel M, Ackenheil M, Müller N: Discrimination between treatment effects and immunologic abnormalities in schizophrenics by measuring autoantibodies, soluble cytokine receptors and soluble ICAM-1 (abstract). Pharmacopsychiatry 1997;30:222
5. Birnbaum G: Stress proteins: their role in the normal central nervous system and in disease states, especially multiple sclerosis, in Immunoneurology. Edited by Chofflon M, Steinman L. New York, Springer-Verlag, 1996, pp 107-118
6. Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52:998-1007
7. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT: Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995; 52: 829-836
8. Brenneman DE, Gozes I: A femtomolar-acting neuroprotective peptide. J Clin Invest 1996; 97:2299-2307